Future HIV Therapy logo Future Medicine logo

Future HIV Therapy keeps clinicians and researchers up to date with the significant advances that will enable us to develop new treatments to target the virus and any resistant strains that might develop, and also to improve side effects, adherence and education in therapy, and simplify drug regimens and reduce costs.

Publisher: Future Medicine

More about this publication?
Related content
Volume 2, Number 5, September 2008

< previous issue | all issues | next issue >

Editorial

The number of HIV-infected individuals decreases by half in India: impact on the global epidemiology of HIV/AIDS
pp. 395-398(4)
Authors: Venkatesh, Kartik K; Kumarasamy, Nagalingeswaran

Letter to the Editor

Male circumcision is an efficacious, lasting and cost-effective strategy for combating HIV in high-prevalence AIDS epidemics
pp. 399-405(7)
Authors: Halperin, Daniel T; Wamai, Richard G; Weiss, Helen A; Hankins, Catherine; Agot, Kawango; Karim, Quarraisha Abdool; Shisana, Olive; Bailey, Robert C; Betukumesu, Bilonda; Bongaarts, John; Bowa, Kasonde; Cash, Richard; Cates, Ward; Diallo, Mamadou Otto; Dludlu, Sibongile; Geffen, Nathan; Heywood, Mark; Jackson, Helen; Kayembe, Patrick Kalambayi; Kapiga, Saidi; Kebaabetswe, Poloko; Kintaudi, Leon; Klausner, Jeffrey D; Leclerc-Madlala, Suzanne; Mabuza, Khanya; Makhubele, Mzamani Benjamin; Micheni, Kenneth; Morris, Brian J; de Moya, Antonio; Ncala, Johanna; Ntaganira, Innocent; Nyamucherera, Obrian F; Otolorin, Emmanuel Oladipo; Pape, Jean William; Phiri, Mannasseh; Rees, Helen; Ruiz, Monica; Sanchez, Jorge; Sawires, Sharif; Seloilwe, Esther Salang; Serwadda, David M; Setswe, Geoffrey; Sewankambo, Nelson; Simelane, Dudu; Venter, Franççois; Wilson, David; Woelk, Godfrey; Zungu, Nompumelelo

Bulletin Board

Bulletin Board
pp. 407-409(3)

Drug Evaluation

Elvitegravir: an emerging HIV integrase inhibitor
pp. 411-418(8)
Authors: Shimura, Kazuya; Kodama, Eiichi

Special Report

Virtual Physiological Human research initiative: the future for rational HIV treatment design?
pp. 419-425(7)
Authors: Stoica, Ileana; Sadiq, S Kashif; Gale, Catherine V; Coveney, Peter V

Unmet need and access to HIV services in Europe
pp. 427-435(9)
Authors: de Sa, Joia; Mounier-Jack, Sandra; Lock, Karen; Coker, Richard J

Review

The white and the three-letter plague: integration of TB and HIV care in sub-Saharan Africa
pp. 437-451(15)
Authors: Wallrauch, Claudia; Bäärnighausen, Till; Heller, Tom; Houlihan, Catherine; Newell, Marie-Louise

Prophylaxis and treatment of malaria in HIV-infected populations
pp. 453-464(12)
Authors: Achan, Jane; Gasasira, Anne F; Aweeka, Fran; Havlir, Diane; Rosenthal, Philip J; Kamya, Moses R

Clinical significance of HIV-associated bone loss: when and how to intervene
pp. 465-478(14)
Authors: Yin, Michael T; Shane, Elizabeth; Anastos, Kathryn

Update on the development of HIV entry inhibitors
pp. 479-507(29)
Authors: Mastrolorenzo, Antonio; Maresca, Alfonso; Rusconi, Stefano; Supuran, Claudiu T

Acknowledgements

Acknowledgements
pp. 513-513(1)

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page